Biolexis Therapeutics has achieved a transformative milestone in metabolic drug discovery with the successful resolution of ...

While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that ...

Although GLP-1 drugs have shown impressive results for ... There are a number of ways to structure coverage to meets the needs of workers and employers alike. “We have a number of clients ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

The farnesoid X receptor (FXR) is a bile acid nuclear receptor that plays a crucial role in regulating bile acid and sterol metabolism.

Novo Nordisk and Eli Lilly currently control 99% of the market, but their dominance may weaken as new entrants introduce ...

After making waves globally and helping people lose weight—not counting the side effects—the wonder-drug Ozempic is now in ...

Social support can improve the odds of successful weight loss. AnnaLee Canario and Dacia Benjamin say their friendship is the ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

During a Case-Based Roundtable® event, Vamsidhar Velcheti, MD, discussed the TRIDENT-1 trial and practical considerations for ...

In this deep dive, BioSpace explores the diverse therapeutic modalities now in development, as well as the opportunities and ...